366 related articles for article (PubMed ID: 9685390)
1. Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2.
Tamai I; Ohashi R; Nezu J; Yabuuchi H; Oku A; Shimane M; Sai Y; Tsuji A
J Biol Chem; 1998 Aug; 273(32):20378-82. PubMed ID: 9685390
[TBL] [Abstract][Full Text] [Related]
2. Molecular cloning and functional characterization of the OCTN2 transporter at the RBE4 cells, an in vitro model of the blood-brain barrier.
Friedrich A; Prasad PD; Freyer D; Ganapathy V; Brust P
Brain Res; 2003 Apr; 968(1):69-79. PubMed ID: 12644265
[TBL] [Abstract][Full Text] [Related]
3. Functional domains in the carnitine transporter OCTN2, defective in primary carnitine deficiency.
Amat di San Filippo C; Wang Y; Longo N
J Biol Chem; 2003 Nov; 278(48):47776-84. PubMed ID: 14506273
[TBL] [Abstract][Full Text] [Related]
4. Functional and pharmacological characterization of human Na(+)-carnitine cotransporter hOCTN2.
Wagner CA; Lükewille U; Kaltenbach S; Moschen I; Bröer A; Risler T; Bröer S; Lang F
Am J Physiol Renal Physiol; 2000 Sep; 279(3):F584-91. PubMed ID: 10966938
[TBL] [Abstract][Full Text] [Related]
5. Tyrosine residues affecting sodium stimulation of carnitine transport in the OCTN2 carnitine/organic cation transporter.
Amat di San Filippo C; Longo N
J Biol Chem; 2004 Feb; 279(8):7247-53. PubMed ID: 14665638
[TBL] [Abstract][Full Text] [Related]
6. Studies on functional sites of organic cation/carnitine transporter OCTN2 (SLC22A5) using a Ser467Cys mutant protein.
Ohashi R; Tamai I; Inano A; Katsura M; Sai Y; Nezu J; Tsuji A
J Pharmacol Exp Ther; 2002 Sep; 302(3):1286-94. PubMed ID: 12183691
[TBL] [Abstract][Full Text] [Related]
7. Transport of L-carnitine in human corneal and conjunctival epithelial cells.
Xu S; Flanagan JL; Simmons PA; Vehige J; Willcox MD; Garrett Q
Mol Vis; 2010 Sep; 16():1823-31. PubMed ID: 21045919
[TBL] [Abstract][Full Text] [Related]
8. Molecular and physiological evidence for multifunctionality of carnitine/organic cation transporter OCTN2.
Ohashi R; Tamai I; Nezu Ji J; Nikaido H; Hashimoto N; Oku A; Sai Y; Shimane M; Tsuji A
Mol Pharmacol; 2001 Feb; 59(2):358-66. PubMed ID: 11160873
[TBL] [Abstract][Full Text] [Related]
9. Molecular cloning and characterization of high-affinity carnitine transporter from rat intestine.
Sekine T; Kusuhara H; Utsunomiya-Tate N; Tsuda M; Sugiyama Y; Kanai Y; Endou H
Biochem Biophys Res Commun; 1998 Oct; 251(2):586-91. PubMed ID: 9792817
[TBL] [Abstract][Full Text] [Related]
10. Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/carnitine transporter.
Wu X; Huang W; Prasad PD; Seth P; Rajan DP; Leibach FH; Chen J; Conway SJ; Ganapathy V
J Pharmacol Exp Ther; 1999 Sep; 290(3):1482-92. PubMed ID: 10454528
[TBL] [Abstract][Full Text] [Related]
11. Involvement of carnitine/organic cation transporter OCTN2 (SLC22A5) in distribution of its substrate carnitine to the heart.
Iwata D; Kato Y; Wakayama T; Sai Y; Kubo Y; Iseki S; Tsuji A
Drug Metab Pharmacokinet; 2008; 23(3):207-15. PubMed ID: 18574325
[TBL] [Abstract][Full Text] [Related]
12. Na(+)-coupled transport of L-carnitine via high-affinity carnitine transporter OCTN2 and its subcellular localization in kidney.
Tamai I; China K; Sai Y; Kobayashi D; Nezu J; Kawahara E; Tsuji A
Biochim Biophys Acta; 2001 Jun; 1512(2):273-84. PubMed ID: 11406104
[TBL] [Abstract][Full Text] [Related]
13. Involvement of OCTN2 in the transport of acetyl-L-carnitine across the inner blood-retinal barrier.
Tachikawa M; Takeda Y; Tomi M; Hosoya K
Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):430-6. PubMed ID: 19684012
[TBL] [Abstract][Full Text] [Related]
14. Functional relevance of carnitine transporter OCTN2 to brain distribution of L-carnitine and acetyl-L-carnitine across the blood-brain barrier.
Kido Y; Tamai I; Ohnari A; Sai Y; Kagami T; Nezu J; Nikaido H; Hashimoto N; Asano M; Tsuji A
J Neurochem; 2001 Dec; 79(5):959-69. PubMed ID: 11739607
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological and pathophysiological roles of carnitine/organic cation transporters (OCTNs: SLC22A4, SLC22A5 and Slc22a21).
Tamai I
Biopharm Drug Dispos; 2013 Jan; 34(1):29-44. PubMed ID: 22952014
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of L-carnitine transport in cultured human hepatoma HLF cells.
Yokogawa K; Miya K; Tamai I; Higashi Y; Nomura M; Miyamoto K; Tsuji A
J Pharm Pharmacol; 1999 Aug; 51(8):935-40. PubMed ID: 10504033
[TBL] [Abstract][Full Text] [Related]
17. Functional regions of organic cation/carnitine transporter OCTN2 (SLC22A5): roles in carnitine recognition.
Inano A; Sai Y; Kato Y; Tamai I; Ishiguro M; Tsuji A
Drug Metab Pharmacokinet; 2004 Jun; 19(3):180-9. PubMed ID: 15499185
[TBL] [Abstract][Full Text] [Related]
18. Mutations in novel organic cation transporter (OCTN2), an organic cation/carnitine transporter, with differential effects on the organic cation transport function and the carnitine transport function.
Seth P; Wu X; Huang W; Leibach FH; Ganapathy V
J Biol Chem; 1999 Nov; 274(47):33388-92. PubMed ID: 10559218
[TBL] [Abstract][Full Text] [Related]
19. Structural and functional characteristics and tissue distribution pattern of rat OCTN1, an organic cation transporter, cloned from placenta.
Wu X; George RL; Huang W; Wang H; Conway SJ; Leibach FH; Ganapathy V
Biochim Biophys Acta; 2000 Jun; 1466(1-2):315-27. PubMed ID: 10825452
[TBL] [Abstract][Full Text] [Related]
20. Mutations in the organic cation/carnitine transporter OCTN2 in primary carnitine deficiency.
Wang Y; Ye J; Ganapathy V; Longo N
Proc Natl Acad Sci U S A; 1999 Mar; 96(5):2356-60. PubMed ID: 10051646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
